Anne ORiordan - 02 Aug 2024 Form 4 Insider Report for Jazz Pharmaceuticals plc (JAZZ)

Role
Director
Signature
By: /s/Adam Guttmann, as attorney in fact For: Anne O'Riordan
Issuer symbol
JAZZ
Transactions as of
02 Aug 2024
Net transactions value
-$165,243
Form type
4
Filing time
06 Aug 2024, 18:40:48 UTC
Previous filing
15 Aug 2023
Next filing
11 Aug 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction JAZZ Ordinary Shares Award $0 +3,731 +30% $0.000000 16,282 02 Aug 2024 Direct F1
transaction JAZZ Ordinary Shares Tax liability $165,243 -1,484 -9.1% $111.35 14,798 06 Aug 2024 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These restricted stock units are granted pursuant to the Issuer's 2007 Amended and Restated Non-Employee Directors Stock Award Plan. Each restricted stock unit represents a contingent right to receive one ordinary share upon the vesting of the unit. Subject to the Reporting Person's continuous service and certain additional conditions, these units will vest in full on July 25, 2025.
F2 Shares sold to satisfy tax obligations arising out of the vesting of previously granted restricted stock units.